Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of rosuvastatin on the echolucency of the common carotid intima-media in low-risk individuals: the METEOR trial.
Lind L, Peters SA, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR 3rd, O'Leary DH, Evans GW, Raichlen JS, Bots ML; METEOR Study Group. Lind L, et al. Among authors: palmer mk. J Am Soc Echocardiogr. 2012 Oct;25(10):1120-1127.e1. doi: 10.1016/j.echo.2012.07.004. Epub 2012 Aug 9. J Am Soc Echocardiogr. 2012. PMID: 22884641 Clinical Trial.
Manual or semi-automated edge detection of the maximal far wall common carotid intima-media thickness: a direct comparison.
Peters SA, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR 3rd, O'Leary DH, Evans GW, Raichlen JS, Lind L, Bots ML; METEOR Study Group. Peters SA, et al. Among authors: palmer mk. J Intern Med. 2012 Mar;271(3):247-56. doi: 10.1111/j.1365-2796.2011.02422.x. Epub 2011 Aug 11. J Intern Med. 2012. PMID: 21726301 Free article. Clinical Trial.
Does baseline carotid intima-media thickness modify the effect of rosuvastatin when compared with placebo on carotid intima-media thickness progression? The METEOR study.
Crouse JR 3rd, Bots ML, Evans GW, Palmer MK, O'Leary DH, Grobbee DE, Raichlen JS; METEOR Study Group. Crouse JR 3rd, et al. Among authors: palmer mk. Eur J Cardiovasc Prev Rehabil. 2010 Apr;17(2):223-9. doi: 10.1097/HJR.0b013e3283359c38. Eur J Cardiovasc Prev Rehabil. 2010. PMID: 20038840 Clinical Trial.
Extensive or restricted ultrasound protocols to measure carotid intima-media thickness: analysis of completeness rates and impact on observed rates of change over time.
Peters SA, den Ruijter HM, Palmer MK, Grobbee DE, Crouse JR 3rd, O'Leary DH, Evans GW, Raichlen JS, Bots ML; METEOR Study Investigators. Peters SA, et al. Among authors: palmer mk. J Am Soc Echocardiogr. 2012 Jan;25(1):91-100. doi: 10.1016/j.echo.2011.09.009. Epub 2011 Oct 7. J Am Soc Echocardiogr. 2012. PMID: 21982737 Free article. Clinical Trial.
C-reactive protein lowering with rosuvastatin in the METEOR study.
Peters SA, Palmer MK, Grobbee DE, Crouse JR 3rd, O'Leary DH, Raichlen JS, Bots ML. Peters SA, et al. Among authors: palmer mk. J Intern Med. 2010 Aug;268(2):155-61. doi: 10.1111/j.1365-2796.2010.02230.x. Epub 2010 Mar 6. J Intern Med. 2010. PMID: 20412373 Free article. Clinical Trial.
Increased age, high body mass index and low HDL-C levels are related to an echolucent carotid intima-media: the METEOR study.
Peters SA, Lind L, Palmer MK, Grobbee DE, Crouse JR 3rd, O'Leary DH, Evans GW, Raichlen J, Bots ML, den Ruijter HM; METEOR study group. Peters SA, et al. Among authors: palmer mk. J Intern Med. 2012 Sep;272(3):257-66. doi: 10.1111/j.1365-2796.2011.02505.x. Epub 2012 Jan 12. J Intern Med. 2012. PMID: 22172243 Free article. Clinical Trial.
93 results